To investigate whether OMD’s binding with BMP2 could disturb the interaction of BMP2 with its cell surface receptors, we performed the Co-IP assay using type I and type II BMP receptors (Fig. 3C). The gene discussed is BMP2; the disease is occult macular dystrophy.